New Delhi, Nov 12 (PTI) Natco Pharma on Wednesday said it has completed the acquisition of 35.75 per cent stake in South Africa-based Adcock Ingram Holdings.

As part of the acquisition process, Adcock, one of South Africa's oldest pharmaceutical companies, has delisted from the Johannesburg Stock Exchange (JSE) as of November 11, 2025, the drug firm said in a statement.

"This landmark event marks the culmination of a strategic acquisition in which Natco Pharma has acquired 35.75 per cent of Adcock Ingram in a transaction valued at around USD 226 million (ZAR 4 billion)," it added.

With roots tracing back to 1891, Adcock Ingram is known for brands such as Panado, Myprodol, Epi-Max, Citro-soda and Allergex.

The company has shaped the pharmaceutical landscape in the region for 135 years.

See Full Page